Logos Global Management’s Olema Pharmaceuticals OLMA Stock Holding History

Logos Global Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.1M	Hold	3,208,875	–	–	1.73%	18
2026 Q1	$47.8M	Hold	3,208,875	–	–	2.39%	10
2025 Q4	$80.2M	Hold	3,208,875	–	–	4.85%	4
2025 Q3	$31.4M	Hold	3,208,875	–	–	2.82%	12
2025 Q2	$13.7M	Hold	3,208,875	–	–	1.51%	24
2025 Q1	$12.1M	Hold	3,208,875	–	–	2.14%	18
2024 Q4	$18.7M	Hold	3,208,875	–	–	2.19%	17
2024 Q3	$38.3M	Hold	3,208,875	–	–	4.13%	6
2024 Q2	$34.7M	Sell	3,208,875 -1,175,000	-27%	-$12.7M	2.79%	11
2024 Q1	$49.6M	Hold	4,383,875	–	–	4.02%	8
2023 Q4	$54.4M	Buy	4,383,875 +640,000	+17%	+$8.6M	5.08%	7
2023 Q3	$46.2M	Hold	3,743,875	–	–	6.17%	3
2023 Q2	$33.8M	Hold	3,743,875	–	–	4.6%	6
2023 Q1	$13M	Hold	3,743,875	–	–	1.86%	23
2022 Q4	$9.17M	Hold	3,743,875	–	–	1.07%	26
2022 Q3	$10.3M	Hold	3,743,875	–	–	1.27%	22
2022 Q2	$15.2M	Hold	3,743,875	–	–	2.8%	15
2022 Q1	$15.9M	Hold	3,743,875	–	–	2.07%	20
2021 Q4	$35M	Hold	3,743,875	–	–	3.61%	13
2021 Q3	$103M	Hold	3,743,875	–	–	7.44%	2
2021 Q2	$105M	Hold	3,743,875	–	–	8.8%	2
2021 Q1	$124M	Hold	3,743,875	–	–	12.12%	2
2020 Q4	$180M	Buy	+3,743,875	New	+$176M	15.43%	2

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Logos Global Management's OLMA Position: Q2 2026 in Review

Logos Global Management held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 3,208,875 shares worth $40.1M. The position accounts for 1.73% of the portfolio, ranked #18.

Logos Global Management first reported a position in OLMA in Q4 2020 and has held it in 23 quarters since. The position peaked at $180M in Q4 2020. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Logos Global Management held 3,208,875 shares of Olema Pharmaceuticals worth $40.1M as of Q2 2026.
Logos Global Management left its Olema Pharmaceuticals share count unchanged in Q2 2026.
Olema Pharmaceuticals made up 1.73% of Logos Global Management's portfolio in Q2 2026, its #18 holding.
Logos Global Management first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
Logos Global Management's Olema Pharmaceuticals position peaked at $180M in Q4 2020.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.